Supplementary Figure 1 from Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study
Year: 2025
Type: supplementary-materials
Abstract: CRISPR (Achilles project) survival comparisons to bisacodyl activity.
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4408033728
